-
·
Therapeutic Potential of the Compounds
Mebendazole, Fenbendazole, 2-DG, Ivermectin, DCA, 4-PBA, and DON in Cancer, ALS, Diabetes, and Epilepsy Introduction This article provides an expert overview of several compounds—Mebendazole, Fenbendazole, 2-Deoxy-D-Glucose, Ivermectin, Sodium Dichloroacetate, Sodium 4-Phenylbutyrate, and 6-Diazo-5-Oxo-L-Nor-Leucine—and their potential therapeutic applications in cancer, amyotrophic lateral sclerosis (ALS), aldose reductase diabetes (ALD), diabetes, and epilepsy. Mebendazole Mechanism of Action: Mebendazole…
-
·
Hybrid Orthomolecular Protocol for Cancer: Mitochondrial Insights
Original Article: Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol A Novel Approach to Cancer Treatment: Integrating the Mitochondrial-Stem Cell Connection Theory On September 19, 2024, a groundbreaking protocol in integrative cancer treatment was peer-reviewed and published in a scientific journal, marking a significant advancement in the field. This innovative work…
-
·
Ketogenic Metabolic Therapy – Glioblastoma Treatment
Conclusion of the Clinical Research Framework Proposal for Ketogenic Metabolic Therapy in Glioblastoma Introduction This article serves as a conclusion to the original clinical research framework proposal for ketogenic metabolic therapy (KMT) in glioblastoma (GBM) treatment. As one of the most aggressive forms of cancer, GBM presents significant challenges in terms of effective treatment and…
-
·
Targeting Metastatic Cancer
The Role of Caloric Restriction and Glutamine Targeting in the Press-Pulse Therapeutic Strategy Introduction The management of metastatic cancer presents significant challenges, particularly due to the metabolic diversity of tumors. While some tumors primarily utilize glucose for energy, others are heavily reliant on glutamine. The Press-Pulse therapeutic strategy, as outlined by Seyfried et al. (2017),…